FDA approves Shire's keenly-watched eye drug

July 11 (Reuters) - The U.S. Food and Drug Administration on

Monday approved Shire Plc's lifitegrast eye drops for

treating signs and symptoms of dry eye disease, allowing the

company to bring to...

Read more